Alector Licenses AL050 to Genentech for $100M Upfront
Alector granted Genentech exclusive global rights to develop and commercialize AL050. Alector will receive $100M upfront and is eligible for up to $1.17B in milestones, plus tiered royalties.
Alector said it has granted Genentech exclusive global rights to develop and commercialize AL050. 17B in milestones, plus tiered royalties. Genentech will lead development, regulatory, manufacturing and commercialization.